One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO

• Mark R. Barakat, MD

• Video
• Published 2020

See more

• Updates from the Field
• Mark R. Barakat, MD